Series C - Theranica

Series C - Theranica

Investment Firm

Overview

Theranica is an Israeli biomedical technology company focused on developing electronic and wireless communication technology.

Announced Date

Aug 29, 2022

Funding Type

Series C

Highlights

Location

Asia

Social

Investor Lead

New Rhein

New Rhein

New Rhein is a early_stage_venture and venture firm.

Participant Investors

5

Investor Name
Participant InvestorTakoa Invest
Participant InvestorNew Rhein
Participant InvestorLionBird
Participant InvestorLightspeed Venture Partners
Participant InvestoraMoon Fund

Round Details and Background

Theranica raised $45000000 on 2022-08-29 in Series C

Theranica is an Israeli biomedical technology company focused on developing electronic and wireless communication technology.

Company Funding History

4

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Mar 18, 2019
Series B - Theranica
6-35.0M
Aug 29, 2022
Series C - Theranica
6-45.0M
Jul 03, 2017
Series A - Theranica
3-6.0M
Sep 21, 2016
Seed Round - Theranica
1-undefined

Recent Activity

There is no recent news or activity for this profile.